Cell Stem Cell-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2024-03-07 122472f2m86(暂无昵称) 来自湖北省

2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2023-04-02 ms9000001428733424 来自北京

偏重的研究方向：干细胞;iPS
经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。

140 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2021-12-27 MS54455111222

什么叫实验室常规使用方法？

462 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2021-12-27 MS68862005

方法部分什么时候需要详细描述，什么时候可以简写？

445 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2021-08-17 千寻1076

血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。

417 0

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2021-04-09 张晓梅-Xiaomei Zhang

审稿速度:1.0 | 投稿命中率:5.0
经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发

441 0

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2017-07-16 gu_8183

谁能预测明年会有多少分?

862 0

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2016-08-23 ms5555773950699506

审稿速度:3.0 | 投稿命中率:25.0
经验分享：真正的科研期刊，质量第一。

525 0

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2015-10-17 ruipinsu

cell大树下好乘凉啊，努力的目标

900 0

[GetPortalCommentsPageByObjectIdResponse(id=2191888, encodeId=6929219188853, content=2月8号投稿，11号送审，现在状态还是under review，再过不久应该就有消息了，好忐忑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ded82319242, createdName=122472f2m86(暂无昵称), createdTime=Thu Mar 07 16:17:34 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2123259, encodeId=bd5c21232593c, content=偏重的研究方向：干细胞;iPS 经验分享：1月29号投，1月31号返回邮件，直接被拒，速度贼快。意见是文章内容不够突破性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ec8220098, createdName=ms9000001428733424, createdTime=Sun Apr 02 10:44:32 CST 2023, time=2023-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1088519, encodeId=433610885194e, content=什么叫实验室常规使用方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088520, encodeId=8c881088520de, content=方法部分什么时候需要详细描述，什么时候可以简写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008639, encodeId=fedd10086394d, content=血液领域投了一篇，一周后被拒，没有送审，editor意见是williamhill asia 的研究更适合血液领域的期刊，对干细胞领域学者可能吸引力不够。从拒信可以看出editor非常认真的阅读了williamhill asia 的文章，要求很高，希望未来能够有新的工作投到这个杂志上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Tue Aug 17 11:11:54 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955513, encodeId=12cd95551335, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：这么久没人评论了么，这期刊现在是干细胞领域顶级期刊。非常的难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Apr 09 16:40:58 CST 2021, time=2021-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544468, encodeId=cb16544468a7, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=862, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833350, encodeId=5d4183335060, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：真正的科研期刊，质量第一。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=525, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f725414089, createdName=ms5555773950699506, createdTime=Tue Aug 23 10:16:05 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516079, encodeId=ff075160e9ae, content=cell大树下好乘凉啊，努力的目标, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=900, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Sat Oct 17 23:20:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472391, encodeId=e11b4e2391a4, content=刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1018, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=big easy, createdTime=Thu Nov 04 13:22:00 CST 2010, time=2010-11-04, status=1, ipAttribution=)]

2010-11-04 big easy

刚创刊的时候比较容易发，做点ips就行，现在比较难了，创新性要求较高

1018 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务